GLP-1s hold promise as a potential treatment for alcohol and substance use disorders, according to an expert endocrine ...
Milestone advances MEAI-based therapy targeting a global Alcohol Use Disorder treatment market projected to surpass $20 billion by 2032Vancouver, ...
Sinclair Method uses naltrexone, a medication that is often used for the treatment of opioid use disorder, to reduce the ...
Getty Images The limited treatment options available for alcohol use disorder emphasize the urgent need for more research into pharmacological therapies. While more research is needed, preclinical and ...
Clearmind Medicine Inc. ((TSE:CMND)) announced an update on their ongoing clinical study.Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing ...
Pemvidutide is a novel, peptide-based GLP-1/glucagon dual receptor agonist. The Food and Drug Administration (FDA) has granted Fast Track designation to pemvidutide for the treatment of alcohol use ...
Please provide your email address to receive an email when new articles are posted on . Pharmacotherapy appears to be underused in alcohol use disorder, especially among those with related liver ...
Baclofen, a GABA B receptor agonist traditionally used as a muscle relaxant, has emerged as a promising pharmacological option in the management of Alcohol Use Disorder (AUD). By modulating inhibitory ...
Justdial on MSN
Alcohol Use Disorder: All the Treatment Options
Find effective treatment options, support strategies and what to expect during recovery from alcohol use disorder to achieve ...
Naltrexone can help people cut back on how much alcohol they drink but is best used alongside behavioral and psychosocial support programs. A pill that costs less than a dollar has been called the ...
Getty Images The limited treatment options available for alcohol use disorder emphasize the urgent need for more research into pharmacologic therapies. While more research is needed, preclinical and ...
Disulfiram, often known by the brand name Antabuse, was approved by the FDA-in 1951 as a first-line treatment for patients with alcohol abuse disorder (AUD). Most physicians today don't prescribe it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results